Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Sams

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Toxics|October 21, 2017
Urinary Naphthol as a Biomarker of Exposure: Results from an Oral Exposure to Carbaryl and Workers Occupationally Exposed to NaphthaleneCraig Sams
Toxicology Letters|November 2, 2010
Human volunteer studies investigating the potential for toxicokinetic interactions between the pesticides deltamethrin; pirimicarb and chlorpyrifos-methyl following oral exposure at the acceptable daily intakeCraig Sams, Kate Jones
Frontiers in Pharmacology|December 19, 2019
Development, Testing, Parameterization, and Calibration of a Human Physiologically Based Pharmacokinetic Model for the Plasticizer, Hexamoll<sup>®</sup> Diisononyl-Cyclohexane-1, 2-Dicarboxylate Using <i>In Silico</i>, <i>In Vitro</i>, and Human Biomonitoring DataKevin McNally, Craig Sams, George Loizou
Toxicology Letters|February 2, 2010
Biological monitoring for exposure to pirimicarb: method development and a human oral dosing studyCraig Sams, Katan Patel, Kate Jones
Frontiers in Pharmacology|April 10, 2023
Development, testing, parameterisation, and calibration of a human PBK model for the plasticiser, di (2-ethylhexyl) adipate (DEHA) using <i>in silico</i>, <i>in vitro</i> and human biomonitoring dataKevin McNally, Craig Sams, George Loizou
Frontiers in Pharmacology|March 9, 2023
Development, testing, parameterisation, and calibration of a human PBPK model for the plasticiser, di-(2-ethylhexyl) terephthalate (DEHTP) using <i>in silico</i>, <i>in vitro</i> and human biomonitoring dataKevin McNally, Craig Sams, Alex Hogg, et al.
Journal of Biochemical and Molecular Toxicology|March 5, 2003
A quantitative structure-activity relationship analysis on a series of alkyl benzenes metabolized by human cytochrome p450 2E1David F V Lewis, Craig Sams, George D Loizou
Toxicology Letters|April 24, 2004
Metabolism of ethylbenzene by human liver microsomes and recombinant human cytochrome P450s (CYP)Craig Sams, George D Loizou, John Cocker, et al.
Frontiers in Pharmacology|September 20, 2021
Development, Testing, Parameterisation and Calibration of a Human PBPK Model for the Plasticiser, Di-(2-propylheptyl) Phthalate (DPHP) Using in Silico, <i>in vitro</i> and Human Biomonitoring DataKevin McNally, Craig Sams, Alex Hogg, et al.
Frontiers in Toxicology|April 7, 2022
Biological Monitoring: Evidence for Reductions in Occupational Exposure and RiskJackie Morton, Craig Sams, Elizabeth Leese, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Toxics|October 21, 2017
Urinary Naphthol as a Biomarker of Exposure: Results from an Oral Exposure to Carbaryl and Workers Occupationally Exposed to NaphthaleneCraig Sams
Toxicology Letters|November 2, 2010
Human volunteer studies investigating the potential for toxicokinetic interactions between the pesticides deltamethrin; pirimicarb and chlorpyrifos-methyl following oral exposure at the acceptable daily intakeCraig Sams, Kate Jones
Frontiers in Pharmacology|December 19, 2019
Development, Testing, Parameterization, and Calibration of a Human Physiologically Based Pharmacokinetic Model for the Plasticizer, Hexamoll<sup>®</sup> Diisononyl-Cyclohexane-1, 2-Dicarboxylate Using <i>In Silico</i>, <i>In Vitro</i>, and Human Biomonitoring DataKevin McNally, Craig Sams, George Loizou
Toxicology Letters|February 2, 2010
Biological monitoring for exposure to pirimicarb: method development and a human oral dosing studyCraig Sams, Katan Patel, Kate Jones
Frontiers in Pharmacology|April 10, 2023
Development, testing, parameterisation, and calibration of a human PBK model for the plasticiser, di (2-ethylhexyl) adipate (DEHA) using <i>in silico</i>, <i>in vitro</i> and human biomonitoring dataKevin McNally, Craig Sams, George Loizou
Frontiers in Pharmacology|March 9, 2023
Development, testing, parameterisation, and calibration of a human PBPK model for the plasticiser, di-(2-ethylhexyl) terephthalate (DEHTP) using <i>in silico</i>, <i>in vitro</i> and human biomonitoring dataKevin McNally, Craig Sams, Alex Hogg, et al.
Journal of Biochemical and Molecular Toxicology|March 5, 2003
A quantitative structure-activity relationship analysis on a series of alkyl benzenes metabolized by human cytochrome p450 2E1David F V Lewis, Craig Sams, George D Loizou
Toxicology Letters|April 24, 2004
Metabolism of ethylbenzene by human liver microsomes and recombinant human cytochrome P450s (CYP)Craig Sams, George D Loizou, John Cocker, et al.
Frontiers in Pharmacology|September 20, 2021
Development, Testing, Parameterisation and Calibration of a Human PBPK Model for the Plasticiser, Di-(2-propylheptyl) Phthalate (DPHP) Using in Silico, <i>in vitro</i> and Human Biomonitoring DataKevin McNally, Craig Sams, Alex Hogg, et al.
Frontiers in Toxicology|April 7, 2022
Biological Monitoring: Evidence for Reductions in Occupational Exposure and RiskJackie Morton, Craig Sams, Elizabeth Leese, et al.
Pageof 2